These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16865272)

  • 41. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentially expressed genes associated with human lung cancer.
    Xiao W; Pacyna-Gengelbach M; Schlüns K; An Q; Gao Y; Cheng S; Petersen I
    Oncol Rep; 2005 Jul; 14(1):229-34. PubMed ID: 15944794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
    Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
    Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A training-testing approach to the molecular classification of resected non-small cell lung cancer.
    Yamagata N; Shyr Y; Yanagisawa K; Edgerton M; Dang TP; Gonzalez A; Nadaf S; Larsen P; Roberts JR; Nesbitt JC; Jensen R; Levy S; Moore JH; Minna JD; Carbone DP
    Clin Cancer Res; 2003 Oct; 9(13):4695-704. PubMed ID: 14581339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
    Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
    Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.
    Wigle DA; Jurisica I; Radulovich N; Pintilie M; Rossant J; Liu N; Lu C; Woodgett J; Seiden I; Johnston M; Keshavjee S; Darling G; Winton T; Breitkreutz BJ; Jorgenson P; Tyers M; Shepherd FA; Tsao MS
    Cancer Res; 2002 Jun; 62(11):3005-8. PubMed ID: 12036904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical role of MDR1 gene expression in human lung cancer.
    Oka M; Fukuda M; Sakamoto A; Takatani H; Fukuda M; Soda H; Kohno S
    Anticancer Res; 1997; 17(1B):721-4. PubMed ID: 9066608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
    Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
    Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candidate genes upregulated in density dependent growth inhibition of lung cancer cells.
    Kuhn H; Bräunlich J; Hammerschmidt S; Wirtz H
    Int J Oncol; 2004 Nov; 25(5):1481-7. PubMed ID: 15492842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
    L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
    Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx.
    Liu ZQ; Tian YQ; Hu YF; Li XL; Ma FR; Li GY
    Chin Med J (Engl); 2009 Feb; 122(4):437-43. PubMed ID: 19302751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo.
    Kobayashi K; Nishioka M; Kohno T; Nakamoto M; Maeshima A; Aoyagi K; Sasaki H; Takenoshita S; Sugimura H; Yokota J
    Oncogene; 2004 Apr; 23(17):3089-96. PubMed ID: 14755238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
    Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
    Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
    Simon G; Sharma A; Li X; Hazelton T; Walsh F; Williams C; Chiappori A; Haura E; Tanvetyanon T; Antonia S; Cantor A; Bepler G
    J Clin Oncol; 2007 Jul; 25(19):2741-6. PubMed ID: 17602079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.